CTRMS 2025 - Virtual

Shoki Suzuki MD, Japan

PhD student
Department of surgery
tohoku university graduate school of medicine

Presentations by Shoki Suzuki MD

from in room Hall A4
Oral Abstract Session — Parallel Session 11: Next-generation strategies in cell and gene therapy 1
Mocravimod, a novel immunosuppressant, not only suppresses immune rejection but also promotes engraftment of intraportally transplanted islets by its anti-inflammatory and anti-coagulant effects

Email: info@ctrms2025.org